Prognostic significance of p53, Her-2, and EGFR overexpression in borderline and epithelial ovarian cancer

This publication has 30 references indexed in Scilit:

• Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma
  Cancer, 2003
• P53 and Bcl-2 as prognostic predictors in epithelial ovarian cancer
  International Journal of Gynecologic Cancer, 2002
• The growth factor receptors HER-2/neu and EGFR, their relationship, and their effects on the prognosis in early stage (FIGO I-II) epithelial ovarian carcinoma
  International Journal of Gynecologic Cancer, 2001
• p53 and bcl-2 in Epithelial Ovarian Carcinoma: Their Value as Prognostic Indicators at a Median Follow-up of 60 Months
  Gynecologic Oncology, 2000
• Coexpression of the HER-2 Gene Product, pl85^HER-2, and Epidermal Growth Factor Receptor, pl70^EGF-R, on Epithelial Ovarian Cancers and Normal Tissues
  Hybridoma, 1998
• Quantification of p53 in Epithelial Ovarian Cancer
  Gynecologic Oncology, 1997
• Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry
  Cytometry, 1997
• p53 overexpression in advanced-stage endometrial adenocarcinoma
  American Journal of Obstetrics and Gynecology, 1996
• Overexpression of the Oncogene c-erb B2 in Primary Ovarian Cancer
  International Journal of Gynecological Pathology, 1994
• Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer
  International Journal of Gynecologic Cancer, 1993